High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$900K
$900,774
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AKBA
S
Akebia Therapeutics, Inc.
Burke Steven Keith
• Officer • SVP, Chief Medical Officer
Sell to Cover
2026-02-02
$94,045x3
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Medical Officer
Sell to Cover
|
2026-02-02 | $94,045x3 | S | Form 4 |
| AKBA |
Akebia Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $474,414x4 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Grund Nicholas
• Officer • Chief Commercial Officer
Sell to Cover
2026-02-02
$117,912x2
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-02-02 | $117,912x2 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Malabre Richard C
• Officer • SVP, Chief Accounting Officer
Sell to Cover
2026-02-02
$68,838x2
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to Cover
|
2026-02-02 | $68,838x2 | S | Form 4 |
| AKBA |
Akebia Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-02 | $48,582 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Rucci Carolyn M.
• Officer • SVP, Chief Legal Officer
Sell to Cover
2026-02-02
$96,983x3
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Legal Officer
Sell to Cover
|
2026-02-02 | $96,983x3 | S | Form 4 |